Li, Jing-Yun <br/><br/>
Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice.  [electronic resource] 

 -  Acta pharmacologica Sinica  Jul 2016 
 - 930-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1745-7254 
<br/><br/><label>Standard No.: </label>10.1038/aps.2016.55  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacokinetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Computer Simulation<br/>Drug Dosage Calculations<br/>Drug Synergism<br/>Erlotinib Hydrochloride--pharmacokinetics<br/>Female<br/>Indoles--pharmacokinetics<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Nude<br/>Models, Biological<br/>Pyrroles--pharmacokinetics<br/>Sunitinib<br/>Xenograft Model Antitumor Assays